Superficial dermal fibroblasts enhance basement membrane and epidermal barrier formation in tissue-engineered skin: Implications for treatment of skin basement membrane disorders

Tissue Engineering - Part A

Volumn 20, Issue 3-4, 2014, Pages 540-552

  Varkey, Mathew ^a   Ding, Jie ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUILDINGS; CELL CULTURE; COLLAGEN; DISEASES; FIBROBLASTS; GLYCOPROTEINS; MEMBRANES; TISSUE;

BARRIER FUNCTIONS; BASEMENT MEMBRANE; BLISTERING DISEASE; COLLAGEN-GLYCOSAMINOGLYCAN MATRICES; DERMAL FIBROBLASTS; EPIDERMAL BARRIER; PROTEOGLYCANS; SKIN DISORDERS;

TISSUE ENGINEERING;

COLLAGEN; COLLAGEN TYPE 7; CYTOKERATIN 5; ENTACTIN; KALININ; PROTEOGLYCAN; UVOMORULIN;

ARTICLE; BASEMENT MEMBRANE; CASE REPORT; CELL SUBPOPULATION; CELL VIABILITY; DERMIS; DERMOEPIDERMAL JUNCTION; EPIDERMIS; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SKIN CELL; SKIN DISEASE; TISSUE CULTURE; TISSUE ENGINEERING; WOUND HEALING;

BASEMENT MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; DERMIS; ELECTRIC CAPACITANCE; EPIDERMIS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; HUMANS; SKIN, ARTIFICIAL; TISSUE ENGINEERING;

EID: 84894218068     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0160     Document Type: Article

References (57)

1. Aumailley, M., and Rousselle, P. Laminins of the dermo-epidermal junction. Matrix Biol 18, 19, 1999.
2. Timpl, R., and Brown, J.C. Supramolecular assembly of basement membranes. Bioessays 18, 123, 1996.
3. Fleischmajer, R., Kuhn, K., Sato, Y., MacDonald, E.D., 2nd, Perlish, J.S., Pan, T.C., Chu, M.L., Kishiro, Y., Oohashi, T., Bernier, S.M., Yamada, Y., and Ninomiya, Y. There is temporal and spatial expression of alpha1 (IV), alpha2 (IV), al-pha5 (IV), alpha6 (IV) collagen chains and beta1 integrins during the development of the basal lamina in an "in vitro" skin model. J Invest Dermatol 109, 527, 1997.
4. Smola, H., Stark, H.J., Thiekotter, G., Mirancea, N., Krieg, T., and Fusenig, N.E. Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organo-typic skin culture. Exp Cell Res 239, 399, 1998.
5. Yamane, Y., Yaoita, H., and Couchman, J.R. Basement membrane proteoglycans are of epithelial origin in rodent skin. J Invest Dermatol 106, 531, 1996.
6. Fusenig, N.E. Epithelial-mesenchymal interactions regulate keratinocyte growth and differentiation in vitro. In: Leigh, I., Lane, B., and Watt, F., eds. The Keratinocyte Handbook. Cambridge: Cambridge University Press, 1994, p. 71.
7. Werner, S., Krieg, T., and Smola, H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 127, 998, 2007.
8. Sorrell, J.M., Baber, M.A., and Caplan, A.I. Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J Cell Physiol 200, 134, 2004.
9. Wang, J., Dodd, C., Shankowsky, H.A., Scott, P.G., and Tredget, E.E. Deep dermal fibroblasts contribute to hyper-trophic scarring. Lab Invest 88, 1278, 2008.
10. Varkey, M., Ding, J., and Tredget, E.E. Differential collagen- glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar. Biomaterials 32, 7581, 2011.
11. Honardoust, D., Varkey, M., Marcoux, Y., Shankowsky, H.A., and Tredget, E.E. Reduced decorin, fibromodulin, and transforming growth factor-beta3 in deep dermis leads to hypertrophic scarring. J Burn Care Res 33, 218, 2012.
12. Christiano, A.M., and Uitto, J. Molecular complexity of the cutaneous basement membrane zone. Revelations from the paradigms of epidermolysis bullosa. Exp Dermatol 5, 1, 1996.
13. Spirito, F., Chavanas, S., Prost-Squarcioni, C., Pulkkinen, L., Fraitag, S., Bodemer, C., Ortonne, J.P., and Meneguzzi, G. Reduced expression of the epithelial adhesion ligand lami-nin 5 in the skin causes intradermal tissue separation. J Biol Chem 276, 18828, 2001.
14. Aberdam, D., Galliano, M.F., Vailly, J., Pulkkinen, L., Boni-fas, J., Christiano, A.M., Tryggvason, K., Uitto, J., Epstein, E.H., Jr., Ortonne, J.P., and et al. Herlitz's junctional epi-dermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LA-MININ-5). Nat Genet 6, 299, 1994.
15. Chan, L.S., Lapiere, J.C., Chen, M., Traczyk, T., Mancini, A.J., Paller, A.S., Woodley, D.T., and Marinkovich, M.P. Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol 135, 569, 1999.
16. Uitto, J., and Christiano, A.M. Molecular basis for the dys-trophic forms of epidermolysis bullosa: mutations in the type VII collagen gene. Arch Dermatol Res 287, 16, 1994.
17. De Luca, M., Pellegrini, G., and Mavilio, F. Gene therapy of inherited skin adhesion disorders: a critical overview. Br J Dermatol 161, 19, 2009.
18. Uitto, J., McGrath, J.A., Rodeck, U., Bruckner-Tuderman, L., and Robinson, E.C. Progress in epidermolysis bullosa research: toward treatment and cure. J Invest Dermatol 130, 1778, 2010.
19. Fine, J.D. Inherited epidermolysis bullosa: past, present, and future. Ann N Y Acad Sci 1194, 213, 2010.
20. Chino, T., Tamai, K., Yamazaki, T., Otsuru, S., Kikuchi, Y., Nimura, K., Endo, M., Nagai, M., Uitto, J., Kitajima, Y., and Kaneda, Y. Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 173, 803, 2008.
21. Tolar, J., Ishida-Yamamoto, A., Riddle, M., McElmurry, R.T., Osborn, M., Xia, L., Lund, T., Slattery, C., Uitto, J., Chris-tiano, A.M., Wagner, J.E., and Blazar, B.R. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 113, 1167, 2009.
22. Prockop, D.J., and Olson, S.D. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood 109, 3147, 2007.
23. Fritsch, A., Loeckermann, S., Kern, J.S., Braun, A., Bosl, M.R., Bley, T.A., Schumann, H., von Elverfeldt, D., Paul, D., Er-lacher, M., Berens von Rautenfeld, D., Hausser, I., Fassler, R., and Bruckner-Tuderman, L. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest 118, 1669, 2008.
24. Boyce, S.T., Kagan, R.J., Yakuboff, K.P., Meyer, N.A., Rie-man, M.T., Greenhalgh, D.G., and Warden, G.D. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg 235, 269, 2002.
25. Wang, J., Ding, J., Jiao, H., Honardoust, D., Momtazi, M., Shankowsky, H.A., and Tredget, E.E. Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process. Wound Repair Regen 19, 274, 2011.
26. Takagi, R., Yamato, M., Murakami, D., Kondo, M., Yang, J., Ohki, T., Nishida, K., Kohno, C., and Okano, T. Preparation of keratinocyte culture medium for the clinical applications of regenerative medicine. J Tissue Eng Regen Med 5, e63, 2011.
27. Powell, H.M., and Boyce, S.T. EDC cross-linking improves skin substitute strength and stability. Biomaterials 27, 5821, 2006.
28. Honardoust, D., Varkey, M., Hori, K., Ding, J., Shankowsky, H.A., and Tredget, E.E. Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hyper-trophic scar. Wound Repair Regen 19, 368, 2011.
29. Andriessen, M.P., Niessen, F.B., Van de Kerkhof, P.C., and Schalkwijk, J. Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study. J Pathol 186, 192, 1998.
30. Machesney, M., Tidman, N., Waseem, A., Kirby, L., and Leigh, I. Activated keratinocytes in the epidermis of hyper-trophic scars. Am J Pathol 152, 1133, 1998.
31. Borradori, L., and Sonnenberg, A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 112, 411, 1999.
32. Fuchs, E., Dowling, J., Segre, J., Lo, S.H., and Yu, Q.C. Integrators of epidermal growth and differentiation: distinct functions for beta 1 and beta 4 integrins. Curr Opin Genet Dev 7, 672, 1997.
33. Burgeson, R.E., and Christiano, A.M. The dermal-epidermal junction. Curr Opin Cell Biol 9, 651, 1997.
34. Clark, R.A., Ghosh, K., and Tonnesen, M.G. Tissue engineering for cutaneous wounds. J Invest Dermatol 127, 1018, 2007.
35. Nguyen, B.P., Gil, S.G., and Carter, W.G. Deposition of la-minin 5 by keratinocytes regulates integrin adhesion and signaling. J Biol Chem 275, 31896, 2000.
36. Ryan, M.C., Lee, K., Miyashita, Y., and Carter, W.G. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 145, 1309, 1999.
37. Marionnet, C., Pierrard, C., Vioux-Chagnoleau, C., Sok, J., Asselineau, D., and Bernerd, F. Interactions between fibro-blasts and keratinocytes in morphogenesis of dermal epidermal junction in a model of reconstructed skin. J Invest Dermatol 126, 971, 2006.
38. Nischt, R., Schmidt, C., Mirancea, N., Baranowsky, A., Mokkapati, S., Smyth, N., Woenne, E.C., Stark, H.J., Bou-kamp, P., and Breitkreutz, D. Lack of nidogen-1 and-2 prevents basement membrane assembly in skin-organotypic coculture. J Invest Dermatol 127, 545, 2007.
39. Kohfeldt, E., Sasaki, T., Gohring, W., and Timpl, R. Nidogen-2: a new basement membrane protein with diverse binding properties. J Mol Biol 282, 99, 1998.
40. Engel, J., Hunter, I., Schulthess, T., Beck, K., Dixon, T.W., and Parry, D.A. Assembly of laminin isoforms by triple-and double-stranded coiled-coil structures. Biochem Soc Trans 19, 839, 1991.
41. Aumailley, M., Battaglia, C., Mayer, U., Reinhardt, D., Nischt, R., Timpl, R., and Fox, J.W. Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int 43, 7, 1993.
42. Fleischmajer, R., Schechter, A., Bruns, M., Perlish, J.S., Macdonald, E.D., Pan, T.C., Timpl, R., and Chu, M.L. Skin fibroblasts are the only source of nidogen during early basal lamina formation in vitro. J Invest Dermatol 105, 597, 1995.
43. Bachinger, H.P., Morris, N.P., Lunstrum, G.P., Keene, D.R., Rosenbaum, L.M., Compton, L.A., and Burgeson, R.E. The relationship of the biophysical and biochemical characteristics of type VII collagen to the function of anchoring fibrils. J Biol Chem 265, 10095, 1990.
44. Ortiz-Urda, S., Garcia, J., Green, C.L., Chen, L., Lin, Q., Veitch, D.P., Sakai, L.Y., Lee, H., Marinkovich, M.P., and Khavari, P.A. Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 307, 1773, 2005.
45. Poschl, E., Schlotzer-Schrehardt, U., Brachvogel, B., Saito, K., Ninomiya, Y., and Mayer, U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131, 1619, 2004.
46. Whitelock, J.M., Melrose, J., and Iozzo, R.V. Diverse cell signaling events modulated by perlecan. Biochemistry 47, 11174, 2008.
47. Farach-Carson, M.C., Brown, A.J., Lynam, M., Safran, J.B., and Carson, D.D. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation. Matrix Biol 27, 150, 2008.
48. Sher, I., Zisman-Rozen, S., Eliahu, L., Whitelock, J.M., Maas-Szabowski, N., Yamada, Y., Breitkreutz, D., Fusenig, N.E., Arikawa-Hirasawa, E., Iozzo, R.V., Bergman, R., and Ron, D. Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation. J Biol Chem 281, 5178, 2006.
49. Utriainen, A., Sormunen, R., Kettunen, M., Carvalhaes, L.S., Sajanti, E., Eklund, L., Kauppinen, R., Kitten, G.T., and Pihlajaniemi, T. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum Mol Genet 13, 2089, 2004.
50. Seppinen, L., Sormunen, R., Soini, Y., Elamaa, H., Heljas-vaara, R., and Pihlajaniemi, T. Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing. Matrix Biol 27, 535, 2008.
51. Schluter, H., Wepf, R., Moll, I., and Franke, W.W. Sealing the live part of the skin: the integrated meshwork of desmo-somes, tight junctions and curvilinear ridge structures in the cells of the uppermost granular layer of the human epidermis. Eur J Cell Biol 83, 655, 2004.
52. Brandner, J.M., Kief, S., Grund, C., Rendl, M., Houdek, P., Kuhn, C., Tschachler, E., Franke, W.W., and Moll, I. Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur J Cell Biol 81, 253, 2002.
53. Tunggal, J.A., Helfrich, I., Schmitz, A., Schwarz, H., Gunzel, D., Fromm, M., Kemler, R., Krieg, T., and Niessen, C.M. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. Embo J 24, 1146, 2005.
54. Fuchs, E. Scratching the surface of skin development. Nature 445, 834, 2007.
55. Dagregorio, G., and Guillet, G. Artificial skin as a valuable adjunct to surgical treatment of a large squamous cell carcinoma in a patient with epidermolysis bullosa. Dermatol Surg 31, 474, 2005.
56. Phillips, J., and Rockwell, W.B. Surgical treatment of recessive dystrophic epidermolysis bullosa in the hand: use of tissue-engineered skin (Apligraf). Ann Plast Surg 50, 441, 2003.
57. Falabella, A.F., Valencia, I.C., Eaglstein, W.H., and Schach-ner, L.A. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 136, 1225, 2000.